Abstract:Ethnopharmacological relevance: The root of Astragalus membranaceus, known as "huang-qi", is one of the most widely used Chinese herbal medicines for the prevention and treatment of myocardial ischemic diseases. However, the mechanisms governing its therapeutic effects are largely unknown.Aims of the study: The aims of the present study were to investigate the cardioprotective effect of the root extract of Astragalu membranaceus (EAM) in myocardial ischemia and to explore its underlying mechanisms in ROS-mediated signaling cascade in vivo and in vitro.Materials and methods: The saponins in EAM were analyzed using HPLC. The tests for the cardioprotective effects of EAM and its mechanisms were performed in vivo and in vitro. In vivo, the rat model of persistent myocardial ischemia was produced by occlusion of the left anterior descending (LAD) coronary artery. In vitro, the cardiomyocyte model of oxidative stress was mimicked by the direct free radical donor, H2O2.Results: In vivo, the Increased myocardial infarct size and the increased serum levels of lactate dehydrogenase (LDH), creatine kinase isoform MB (CK-MB), and cardiac troponin (cTnI) were significantly decreased by pre-treatment with EAM. Moreover, cardiac function, as assessed by +/- dP/dt, left ventricular developed pressure (LVDP), and left ventricular end-diastolic pressure (LVEDP), was dramatically improved. An oxidative stress biomarker, malondialdehyde (MDA), was reduced, and the antioxidant enzyme superoxide dismutase (SOD) was induced. In vitro, H2O2-triggered myocardial cell death and cytoplasm Ca2+ overload were blocked by treatment with EAM. Furthermore, the K-ATP, channel blocker (5-HD, glibenclamide) blocked the anti-apoptotic protective effect of EAM on cardiomyocytes injured by H2O2.Conclusions: The cardioprotection of EAM was manifested as a protection of tissue structure and as a decrease in serum markers of ischemic injury. The mechanisms underlying the EAM-mediated protective effects may involve improving cardiac function, attenuating the oxidative injury via a decrease in MDA, a maintenance in SOD, and a reduction in free radical-induced myocardial cell injury. Additionally, EAM enhanced the myocardial cell viability via arresting the influx of Ca2+ to block cell death and opening mitochondrial K-ATP, channels to reduce cell apoptosis. (C) 2013 Elsevier Ireland Ltd. All rights reserved.

Protective Effect of Astragalosides on Myocardial Injury by Isoproterenol in SD Rats

Protective Action of Astragalosides on Myocardial Injury Induced by Isoproterenol in Rats

Effect of astragalosides on intracellular calcium overload in cultured cardiac myocytes of neonatal rats.

Modification of Alterations in Cardiac Function and Sarcoplasmic Reticulum by Astragaloside Iv in Myocardial Injury in Vivo

Cardioprotective Effects of Astragali Radix Against Isoproterenol‐induced Myocardial Injury in Rats and Its Possible Mechanism

[Auricularia Auricular Polysaccharide Protects Myocardium Against Ischemia/reperfusion Injury].

Cardioprotection Activity and Mechanism of Astragalus Polysaccharide in Vivo and in Vitro

Cardioprotective Effects of Astragalin against Myocardial Ischemia/Reperfusion Injury in Isolated Rat Heart

Effects of astragalosides on the cultivation of calcium overload in rat cardiac myocytes

Protective Effects of Astragaloside Ⅳ on Isoproterenol-Induced Cardiac Hypertrophy in Mice

Protective Effect of Astragaloside on Cardiac Function Injury Induced by Myocardial Ischemia in Beagles

Astragaloside IV attenuates myocardial ischemia/reperfusion injury in rats via inhibition of calcium-sensing receptor-mediated apoptotic signaling pathways

Astragaloside Iv Improved Intracellular Calcium Handling in Hypoxia-Reoxygenated Cardiomyocytes Via the Sarcoplasmic Reticulum Ca2+-Atpase

Astragaloside Iv Protects Heart from Ischemia and Reperfusion Injury Via Energy Regulation Mechanisms

Astragaloside Iv from Astragalus Membranaceus Shows Cardioprotection During Myocardial Ischemia in Vivo and in Vitro

Protective Effect of Astragaloside A on Acute Cerebral Ischemia Reperfusion Injury Induced by Middle Cerebral Artery Occlusion

Extracts from Astragalus Membranaceus Limit Myocardial Cell Death and Improve Cardiac Function in a Rat Model of Myocardial Ischemia.

Protection of Astragaloside Derivate on Oxidative Stress and Hypertrophy in Cardiomyocytes

Astragalosides Rescue Both Cardiac Function and Sarcoplasmic Reticulum Ca2+ Transport in Rats with Chronic Heart Failure

EFFECT OF ASTRAGALOSIDE ON VITAMIN D-RECEPTOR EXPRESSION AFTER ENDOTHELIN-1-INDUCED CARDIOMYOCYTE INJURY

Astragaloside IV promotes pharmacological effect of Descurainia sophia seeds on isoproterenol-induced cardiomyopathy in rats by synergistically modulating the myosin motor